S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)
S&P 500   5,083.63 (+0.27%)
DOW   38,979.33 (+0.08%)
QQQ   437.74 (+0.57%)
AAPL   180.52 (-0.50%)
MSFT   408.56 (+0.21%)
META   487.77 (+0.77%)
GOOGL   136.84 (+0.34%)
AMZN   174.91 (+1.01%)
TSLA   200.12 (-0.95%)
NVDA   792.82 (+2.08%)
NIO   5.66 (+4.24%)
AMD   187.42 (+6.16%)
BABA   74.20 (-0.52%)
T   17.03 (+0.41%)
F   12.45 (+1.22%)
MU   89.78 (+0.08%)
CGC   3.32 (-1.19%)
GE   156.08 (+0.30%)
DIS   111.40 (+0.54%)
AMC   4.44 (-11.02%)
PFE   26.88 (-0.59%)
PYPL   60.56 (+0.51%)
XOM   104.62 (+0.29%)

Ono Pharmaceutical (OPHLY) News Today

$5.39
-0.02 (-0.37%)
(As of 02/28/2024 ET)
SourceHeadline
finance.yahoo.com logoFate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 26 at 5:36 PM
markets.businessinsider.com logoInveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery
markets.businessinsider.com - February 19 at 8:22 AM
finance.yahoo.com logoOno Pharmaceutical Co., Ltd. (OPHLY)
finance.yahoo.com - February 15 at 3:02 PM
globenewswire.com logoNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
globenewswire.com - February 14 at 3:00 AM
barrons.com logoOno Pharmaceutical Co. Ltd.
barrons.com - February 10 at 6:52 PM
markets.businessinsider.com logoOno Pharmaceutical earnings preview: what Wall Street is expecting
markets.businessinsider.com - January 30 at 8:46 PM
finance.yahoo.com logoCall for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X
finance.yahoo.com - January 9 at 8:13 AM
finanznachrichten.de logoThe BioMed X Institute: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
finanznachrichten.de - December 19 at 9:28 AM
finance.yahoo.com logoNikkei Edges 0.2% Lower Amid JPY Strength
finance.yahoo.com - November 28 at 7:30 PM
finance.yahoo.com logoChina Shares Open Lower; Infrastructure Stocks Weigh
finance.yahoo.com - November 27 at 10:45 PM
msn.com logoOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 10.78% to 7.59
msn.com - October 5 at 10:09 AM
finance.yahoo.com logoTwist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
finance.yahoo.com - August 31 at 4:29 AM
markets.businessinsider.com logoTwist Bioscience To Develop Novel Antibodies With Ono Pharma
markets.businessinsider.com - August 31 at 4:29 AM
finance.yahoo.com logoQ2 2023 Fate Therapeutics Inc Earnings Call
finance.yahoo.com - August 9 at 1:18 PM
msn.com logoOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Decreased by 29.33% to 6.89
msn.com - August 3 at 4:16 PM
technews.tmcnet.com logoMacomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer
technews.tmcnet.com - March 23 at 7:51 AM
benzinga.com logoMemo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets
benzinga.com - November 1 at 4:55 AM
finance.yahoo.com logo3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth Stock
finance.yahoo.com - September 19 at 3:47 PM
seekingalpha.com logoFate Therapeutics: Yes For Speculators, No For Defensive Investors
seekingalpha.com - August 30 at 5:04 PM
benzinga.com logoOno Pharmaceutical (OTC:OPHLY), Earnings Estimates, EPS, and Revenue
benzinga.com - July 18 at 11:29 PM
benzinga.com logoOno Pharmaceutical (OTC:OPHLY), Analyst Ratings, Price Targets, Predictions
benzinga.com - July 18 at 6:21 PM
uk.finance.yahoo.com logoCan Ono Pharmaceutical Co ride out the impact of economic shocks?
uk.finance.yahoo.com - July 7 at 2:24 AM
nasdaq.com logoOno Pharmaceutical Co. Ltd ADR (OPHLY)
nasdaq.com - January 23 at 12:52 AM
markets.businessinsider.com logoHere's what to expect from ONO PHARMACEUTICAL's earnings report
markets.businessinsider.com - November 8 at 7:46 PM
Get Ono Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter.



OPHLY Media Mentions By Week

OPHLY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPHLY
News Sentiment

1.04

0.63

Average
Medical
News Sentiment

OPHLY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPHLY Articles
This Week

2

0

OPHLY Articles
Average Week

Get Ono Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:OPHLY) was last updated on 2/29/2024 by MarketBeat.com Staff